359
Participants
Start Date
January 25, 2018
Primary Completion Date
March 18, 2021
Study Completion Date
November 25, 2024
Axicabtagene Ciloleucel
A single infusion of chimeric antigen receptor (CAR)-transduced autologous T cells administered intravenously following a conditioning chemotherapy regimen of fludarabine and cyclophosphamide
Platinum-containing salvage chemotherapy (eg, R-ICE) followed by high dose therapy (eg, BEAM) and autologous stem cell transplant in responders.
Platinum-containing salvage chemotherapy (R-ICE, R-DHAP, R-ESHAP, or R-GDP as selected by treating investigator) followed by high dose therapy (eg, BEAM) and autologous stem cell transplant in responders.
Cyclophosphamide
Administered intravenously
Fludarabine
Administered intravenously
Peter MacCallum Cancer Center, Melbourne
Universitatsklinikum Graz, Division of Hematology, Graz
Medizinische Universitat Innsbruck, Innere Medizin V - Hamatologie und Onkologie, Innsbruck
IOSI, OSpedale Regionale Bellinzona e Valli, Bellinzona
University Hospital Zurich, Zurich
Memorial Sloan Kettering Cancer Center, New York
Icahn School of Medicine at Mount Sinai, New York
Moffitt Cancer Center, Tampa
University of Rochester Medical Center, Rochester
UPMC Hillman Cancer Center, Pittsburgh
Thomas Jefferson University, Philadelphia
IRCCS Ospedale San Raffaele di Milano, Milan
Universitatsklinikum Hamburg-Eppendorf, Hamburg
University of Maryland, Greenbaum Comprehensive Cancer Center, Baltimore
University of Virginia Health System, Charlottesville
Hospital Universitario La Paz, Madrid
Clinica Universidad de Navarra, Pamplona
University of Miami Hospital and Clinics/Sylvester Comprehensive Cancer Center, Miami
Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes
Hospital Universitario de Salamanca, Salamanca
Universitatsmedizin Gottingen, Göttingen
Sarah Cannon Research Institute, Nashville
Henry-Joyce Cancer Center, Nashville
"Instituto di Ematologia L. e A. Seragnoli - Dipartimento di Medicina Specialistica Diagnostica e Sperimentale", Bologna
James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Cleveland Clinic, Cleveland
Barbara Ann Karmanos Cancer Institute, Detroit
University of Iowa Hospitals and Clinincs, Iowa City
Mayo Clinic, Patient Location, Rochester
CHRU de Lille - Hopital Claude Huriez, Lille
Northwestern University, Chicago
University of Chicago Medical Center, Chicago
Washington University School of Medicine, St Louis
The University of Kansas Cancer Center, Kansas City
Universitätsklinikum Heidelberg, Heidelberg
Centre Hospitalier Lyon-Sud - Service d'Hematologie clinique, Pierre-Bénite
Hopital Saint-Louis, Paris
Uppsala Akademiska Sjukhus, Uppsala
The University of Texas, MD Anderson Cancer Center, Houston
University of Utah, Huntsman Cancer Institute, Salt Lake City
Mayo Clinic Hospital, Phoenix
Banner MD Anderson Cancer Center, Gilbert
UCLA, Santa Monica
UC San Diego Moores Cancer Center, La Jolla
Stanford Cancer Institute, Stanford
Universitäts-klinikum Würzburg, Würzburg
Swedish Cancer Institute, Seattle
Tel Aviv Sourasky Medical Center, Tel Aviv
Dana-Farber Cancer Institute, Boston
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Cliniques Universiaires Saint-Luc, Brussels
UZ Gasthuisberg, Leuven
Vancouver General Hospital, Vancouver
University Medical Center Utrecht, Utrecht
CancerCare Manitoba, Winnipeg
Uninversity Health Network - Princess Margaret Cancer Center, Toronto
McGill University Health Center, Montreal
QEII Health Sciences Centre, Halifax
Centre Integre Universitaire de Sante et Services Sociaux de l'Est-de-l'lle-de-Montreal / Hopital Maisonneuve-Rosemont, Montreal
The Ottawa Hospital - General Campus, Ottawa
CHU de Quebec-Universite Laval, Hopital de L'Enfante-Jesus, Québec
Universitäts-klinikum Dresden, Dresden
Academic Medical Center, Amsterdam
University Medical Center Groningen, Groningen
Erasmus Medical Center, Rotterdam
Hospital Clinic de Barcelona, Barcelona
Institut Catala d'Oncologia, Barcelona
University Hospitals Birmingham NHS Foundation Trust, Birmingham
Barts Health NHS Trust, London
University College London Hospitals NHS Foundation Trust, London
The Christie NHS Foundation Trust, Manchester
The Royal Marsden NHS Foundation Trust, Sutton
Kite, A Gilead Company
INDUSTRY